Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Myeloid 4Other hematologic neoplasm 2Classical hematology 2

Conditions

Primary Myelofibrosis 2Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Myeloproliferative Disorders 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 59fludarabine phosphate 53Peripheral Blood Stem Cell Transplantation 43Tacrolimus 40Mycophenolic Acid 36Busulfan 33Whole-Body Irradiation 32Antilymphocyte Serum 28Cyclosporine 27Methotrexate 25fludarabine 19Filgrastim 18Melphalan 17Radiotherapy 15Methylprednisolone 13Etoposide 12Cord Blood Stem Cell Transplantation 12thymoglobulin 11Sirolimus 11ruxolitinib 10Flow Cytometry 10Psychiatric Rehabilitation 9Azacitidine 9Stem Cell Transplantation 7Granulocyte Colony-Stimulating Factor 7Decitabine 7Therapeutics 6Imatinib Mesylate 6Cytarabine 6Cyclosporins 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Primary Myelofibrosis × luspatercept × Other hematologic neoplasm × Clear all
NCT07539779 2026-04-20

Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis

Nanfang Hospital, Southern Medical University

Phase 2/3 Not yet recruiting
196 enrolled
MyeloidOther hematologic neoplasm

Hematologic Neoplasms, Primary Myelofibrosis

NCT01688011 2025-07-03

Connect® Myeloid Disease Registry

Celgene

Terminated
2,013 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡